Leqembi: A Breakthrough Infusion Treatment for Early-Onset Alzheimer’s and Mild Cognitive Impairment

Alzheimer’s disease is a neurological disorder that affects millions of people worldwide. In the state of Mississippi, the disease has a high mortality rate, leaving families devastated. However, the Hattiesburg Clinic has taken a significant step in combating this disease by distributing the groundbreaking Leqembi infusion treatment. The treatment is specifically designed for patients who have been diagnosed with early-onset Alzheimer’s or mild cognitive impairment.

What is Leqembi?

Leqembi, also known as lecanemab, is an infusion treatment that focuses on slowing the progression of Alzheimer’s by targeting antibodies. The treatment works by reducing the amount of amyloid plaques, which are proteins that accumulate in the brain of patients diagnosed with Alzheimer’s disease. These amyloid plaques create blockages that prevent the communication of neurons, resulting in brain degeneration.

Leqembi works by neutralizing these amyloid proteins, which helps to reduce plaque formation and slows cognitive decline. Clinical studies have shown that patients who received treatment had a 22% reduction in cognitive decline in their first year and a 34% reduction in the second year of treatment.

The Use of Leqembi

The Hattiesburg Clinic is a leading provider of the Leqembi infusion treatment for early-onset Alzheimer’s and mild cognitive impairment. Neurologist Dr. Ronald Schwartz is leading the clinic’s use of Leqembi. Currently, 42 patients are taking the infusion treatment, and two more patients will receive treatments later this month.

In addition to Leqembi, the clinic is also exploring preventative strategies such as Alzheimer’s vaccines and next-generation immunotherapies. By catching the disease in the earliest stages, they now have the opportunity to delay brain degeneration and improve patient outcomes.

Getting Coverage for Leqembi Treatment

The Leqembi treatment was approved by the FDA in July 2021, and medical centers across the US have been trying to meet the demand. The Centers for Medicaid and Medicare are covering the cost of treatment, and the Veterans Administration is also prepared to cover the cost of veterans over 65 who qualify.

Alongside the Hattiesburg Clinic, the MIND Center in Jackson has been attempting to expand the use of Leqembi and other treatments for Alzheimer’s patients. These two centers have been working together with the Mississippi chapter of the Alzheimer’s Association to find new ways to treat the disease properly.

Conclusion

There is hope for those who have been diagnosed with early-onset Alzheimer’s or mild cognitive impairment with the Leqembi infusion treatment. Thanks to breakthrough research in neuroscience and medicine, medical professionals can work together to reduce cognitive decline and improve patient outcomes.

As patients and their families continue to battle against Alzheimer’s disease, treatments like Leqembi offer a glimmer of hope in the fight against this devastating illness.

Originally Post From https://www.wdam.com/2024/06/18/hattiesburg-clinic-using-groundbreaking-alzheimers-treatment/

Read more about this topic at
Hattiesburg Clinic using groundbreaking Alzheimer’s treatment
Injected version of Eisai/Biogen Alzheimer’s drug works as …